Literature DB >> 33463382

A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients.

Alan Abdulla1, Tim M J Ewoldt2, Ilse M Purmer3, Anouk E Muller4,5, Diederik Gommers2, Henrik Endeman2, Birgit C P Koch1.   

Abstract

INTRODUCTION: : Emerging studies suggest that antibiotic pharmacokinetics (PK) are difficult to predict in critically ill patients. The high intra- and inter-patient PK variability makes it challenging to accurately predict the appropriate dosage required for a given patient. Identifying patients at risk could help clinicians to consider more individualized dosing regimens and perform therapeutic drug monitoring. We provide an overview of relevant predictors associated with target (non-)attainment of β-lactam antibiotics in critically ill patients. AREAS COVERED: : This narrative review summarizes patient and clinical characteristics that can help to predict the attainment of target serum concentrations and to provide guidance on antimicrobial dose optimization. Literature was searched using Embase and Medline database, focusing on β-lactam antibiotics in critically ill patients. EXPERT OPINION: : Adequate concentration attainment can be anticipated in critically ill patients prior to initiating empiric β-lactam antibiotic therapy based on readily available demographic and clinical factors. Male gender, younger age, and augmented renal clearance were the most significant predictors for target non-attainment and should be considered in further investigations to develop dosing algorithms for optimal β-lactam therapy.

Entities:  

Keywords:  critically ill; predictors; risk factors; target attainment; therapeutic drug monitoring; Β-lactam antibiotics

Mesh:

Substances:

Year:  2021        PMID: 33463382     DOI: 10.1080/17425255.2021.1879049

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  2 in total

1.  Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study.

Authors:  Inge Spronk; Birgit C P Koch; Tim M J Ewoldt; Alan Abdulla; Puck van den Broek; Nicole Hunfeld; Soma Bahmany; Anouk E Muller; Diederik Gommers; Suzanne Polinder; Henrik Endeman
Journal:  BMC Infect Dis       Date:  2022-07-13       Impact factor: 3.667

2.  Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies.

Authors:  Ana Alarcia-Lacalle; Helena Barrasa; Javier Maynar; Andrés Canut-Blasco; Carmen Gómez-González; María Ángeles Solinís; Arantxazu Isla; Alicia Rodríguez-Gascón
Journal:  Pharmaceutics       Date:  2021-06-25       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.